LGALS3 and neoplasm: D’Alessandria et al. developed the 89Zr-DFO-mAb to Gal-3 radiotracer, which was used to evaluate Gal-3 expression in thyroid carcinoma models by in vivo immunoPET imaging and served specific tumor accumulation [30].